Next Article in Journal
Potential Coronaviral Inhibitors of the Nucleocapsid Protein Identified In Silico and In Vitro from a Large Natural Product Library
Next Article in Special Issue
Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
Previous Article in Journal
Synthesis, Characterisation and Mechanism of Action of Anticancer 3-Fluoroazetidin-2-ones
Previous Article in Special Issue
Efficacy of Kan Jang® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(9), 1045; https://doi.org/10.3390/ph15091045
Action Date Notes Link
article xml file uploaded 24 August 2022 14:59 CEST Original file -
article xml uploaded. 24 August 2022 14:59 CEST Update https://www.mdpi.com/1424-8247/15/9/1045/xml
article pdf uploaded. 24 August 2022 14:59 CEST Version of Record https://www.mdpi.com/1424-8247/15/9/1045/pdf
article html file updated 24 August 2022 15:00 CEST Original file -
article html file updated 24 August 2022 15:01 CEST Update -
article html file updated 24 August 2022 21:41 CEST Update -
article html file updated 28 February 2023 10:37 CET Update https://www.mdpi.com/1424-8247/15/9/1045/html
Back to TopTop